Skip to content
10-K

Annual Report

Syndax Pharmaceuticals, Inc. SNDX

0001193125-26-076536

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 23, 2026 88.2M sh
Shares Diluted FY 2025 · Dec 31, 2025 86.63M sh
Shares Diluted FY 2025 · Dec 31, 2024 85.62M sh
Shares Diluted FY 2025 · Dec 31, 2023 70.37M sh
Capex FY 2025 · Dec 31, 2025 $187K
Capex FY 2025 · Dec 31, 2024 $0
Capex FY 2025 · Dec 31, 2023 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 −$322.98M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$274.9M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$160.6M
Short Term Debt FY 2025 · Dec 31, 2025 $343.91M
Short Term Debt FY 2025 · Dec 31, 2024 $343.68M
Short Term Investments FY 2025 · Dec 31, 2025 $259.14M
Short Term Investments FY 2025 · Dec 31, 2024 $418.8M
Cash And Equivalents FY 2025 · Dec 31, 2025 $134.93M
Cash And Equivalents FY 2025 · Dec 31, 2024 $154.08M
Cash And Equivalents FY 2025 · Dec 31, 2023 $295.39M
Stockholders Equity FY 2025 · Dec 31, 2025 $64.63M
Stockholders Equity FY 2025 · Dec 31, 2024 $288.12M
Stockholders Equity FY 2025 · Dec 31, 2023 $554.2M
Stockholders Equity FY 2025 · Dec 31, 2022 $467.45M
Current Liabilities FY 2025 · Dec 31, 2025 $120.12M
Current Liabilities FY 2025 · Dec 31, 2024 $103.55M
Total Liabilities FY 2025 · Dec 31, 2025 $465.08M
Total Liabilities FY 2025 · Dec 31, 2024 $436.69M
Current Assets FY 2025 · Dec 31, 2025 $528.08M
Current Assets FY 2025 · Dec 31, 2024 $603.06M
Total Assets FY 2025 · Dec 31, 2025 $529.71M
Total Assets FY 2025 · Dec 31, 2024 $724.82M
Eps Diluted FY 2025 · Dec 31, 2025 −$3.29
Eps Diluted FY 2025 · Dec 31, 2024 −$3.72
Eps Diluted FY 2025 · Dec 31, 2023 −$2.98
Eps Basic FY 2025 · Dec 31, 2025 −$3.29
Eps Basic FY 2025 · Dec 31, 2024 −$3.72
Eps Basic FY 2025 · Dec 31, 2023 −$2.98
Sga Expense FY 2025 · Dec 31, 2025 $179.68M
Sga Expense FY 2025 · Dec 31, 2024 $120.88M
Sga Expense FY 2025 · Dec 31, 2023 $66.92M
Rd Expense FY 2025 · Dec 31, 2025 $258.78M
Rd Expense FY 2025 · Dec 31, 2024 $241.65M
Rd Expense FY 2025 · Dec 31, 2023 $163.03M
Net Income FY 2025 · Dec 31, 2025 −$285.42M
Net Income FY 2025 · Dec 31, 2024 −$318.76M
Net Income FY 2025 · Dec 31, 2023 −$209.36M
Operating Income FY 2025 · Dec 31, 2025 −$273.08M
Operating Income FY 2025 · Dec 31, 2024 −$339.67M
Operating Income FY 2025 · Dec 31, 2023 −$229.95M
Revenue FY 2025 · Dec 31, 2025 $172.35M
Revenue FY 2025 · Dec 31, 2024 $23.68M
Revenue FY 2025 · Dec 31, 2023 $0